M
Mehmet Kanbay
Researcher at Koç University
Publications - 438
Citations - 12822
Mehmet Kanbay is an academic researcher from Koç University. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 54, co-authored 370 publications receiving 9894 citations. Previous affiliations of Mehmet Kanbay include Bellvitge University Hospital & Fatih University.
Papers
More filters
Journal ArticleDOI
Multilayered Interplay Between Fructose and Salt in Development of Hypertension.
Ozgur C. Eren,Alberto Ortiz,Baris Afsar,Adrian Covic,Masanari Kuwabara,Miguel A. Lanaspa,Richard J. Johnson,Mehmet Kanbay +7 more
Journal ArticleDOI
Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
Yalcin Solak,Mustafa Cetiner,Dimitrie Siriopol,Kayhan Tarim,Baris Afsar,Adrian Covic,Mehmet Kanbay +6 more
TL;DR: The physiologic functions of HIF in erythropoiesis are described with special emphasis on interactions with iron and hepcidin metabolism and inflammation and the results of several phase 1 and 2 studies confirmed the beneficial role of augmenting HIFs for the management of renal anemia.
Journal ArticleDOI
The Future of IL-1 Targeting in Kidney Disease.
TL;DR: Experimental evidence suggests a role of IL-1 in kidney disease and hypertension and targeting IL- 1 showed promising results in high cardiovascular risk patients, hemodialysis and renal transplantation patients, is summarized.
Journal ArticleDOI
Chronodisruption: A Poorly Recognized Feature of CKD.
Sol Carriazo,Adrian M. Ramos,Ana Belen Sanz,Maria Dolores Sanchez-Niño,Mehmet Kanbay,Alberto Ortiz +5 more
TL;DR: Evidence for chronod isruption in CKD and the impact of chronodisruption on CKD manifestations is discussed, potential chrondisruptors are identified, some of them uremic toxins, and their therapeutic implications are discussed, and current unanswered questions on this topic are discussed.
Journal ArticleDOI
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal.
Alexandru Burlacu,Simonetta Genovesi,David Goldsmith,Patrick Rossignol,Alberto Ortiz,Philip A. Kalra,Jolanta Malyszko,Maciej Banach,Mehmet Kanbay,Adrian Covic +9 more
TL;DR: A review of bleeding risk, strength, reliability and usefulness of the bleeding risk scores in advanced CKD patients with chronic atrial fibrillation and recent stent implantation and existing gaps in the recommendations of European Society of Cardiology Guidelines are highlighted.